Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pyramax and Atovaquone-Proguanil for Malaria in Cambodia
NCT03726593Phase 4Unknown
- Sponsor
- Armed Forces Research Institute of Medical Sciences
- Start
- Oct 2018
- Primary completion
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of pyronaridine in Plasmodium falciparum malaria, sponsored by Armed Forces Research Institute of Medical Sciences. Status: unknown.
02
Drugs
pyronaridine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT03726593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03726593.